Indeed, either haploinsufficiency or liver-specific inactivation of FoxO1 have been shown to inhibit gluconeogenesis and reduce fasting hyperglycemia in insulin-resistant mice by decreasing hepatic expression of gluconeogenic genes and improving peripheral glucose tolerance [104,105]. This evidence concerns the gene FOXO1 and Hyperglycemia.